The Technology Commercialization Forum (TCF) is a premier event in Asia that brings together innovators, industry and investors from the region to explore the opportunities that the emerging economies of Asia present and to facilitate its commercialisation.

This year’s event will spotlight on the opportunities, challenges and future trends in
Alternative Energy and Nanobiotechnology.

There will be lively exchange of ideas through plenary sessions with key experts from Alternative Energy and Nanobiotechnology sharing insights and market focus to catalyze connections and create impact.

This twin-focus conference will also showcase some ongoing research and commercial activity in this area in the Asia Pacific region.

FEATURES

Breakout Sessions – hosted by featured guests from both academia and industry, the session highlights a technology theme that addresses the industry trend with presentations included.

Technology Showcases – Each session features 4-6 “pitches” selected from projects proposed by academia and industry from the Asian region who believe they have a marketable innovation. This interactive session encourages the audience to give feedback on the technology, market and opportunity.

Who is coming

The event congregates academics, industry professionals, venture capitalists, government authorities in the field to examine
trends, business opportunities and key issues involved in Alternative Energy and Nanobiotechnology.

Registration Information

To register for this event, please click here

ALTERNATIVE ENERGY - Key Speakers
Challenges for Renewable Energy Development – What Can Asia/Southeast Asia Do?
	Plenary Speaker: Dr. Benjamin Sovacool Energy Policy Centre on Asia and Globalisation Lee Kuan Yew School of Public Policy National University of Singapore
This plenary session will provide a brief assessment of the energy landscape in Asia/Southeast Asia, discuss some of the benefits that renewable energy technologies can offer the region and will look into factors that have and could further impede renewable energy developments and exploitation; focusing primarily on business and utility practices, political and regulatory attitudes and consumer values and interests. The session will also discuss how innovative policy mechanisms can overcome these impediments, emphasizing the role that renewable portfolio standards, feed-in tariffs, and systems benefits funds could play in Southeast Asia in the promotion of renewable energy systems.
Taking On Energy Innovations In Asia - What Does It Take?
	Closing Keynote Speaker: Dr. Michael Quah Executive Director Energy and Environmental Sustainability Strategic Initiatives Concurrent Technologies Corporation, USA
This presentation will take you through the various alternative energy technologies that are actively pursued in various parts of the world. It will challenge the way you think about alternative energy developments; including the way you factor in use of conventional fossil fuels in the entire energy equation.
NANOBIOTECHNOLOGY - Key Speakers
	Nanotechnology and Life Sciences: Science and Business Perspectives
	Plenary Speaker: Dr. Mostafa Analoui Senior Director Pfizer Global Research and Development
This address focuses on critical needs in clinical diagnostics and key challenges in drug discovery and development. Examples of current utility of nanotechnology, as well as ongoing research areas will be provided. Some of the areas that nanobiotechnology could play role through enhancement in current paradigm, as well as new directions in drug development are also discussed. A snapshot of global business and investment environment around nanobiotechnology will be provided. It includes current and projected level of private and government investments, trends in IP ownership, as well as fundamental questions around assessment of investment strategies and risks.
	Nanobiotechnology at the Crossroads: Where Drugs, Devices, and Diagnostics Meet
	Closing Keynote Speaker 1: Mr. Mark Bunger Research Director Lux Research
Presenting technical and business data, this presentation will show how specific technologies from nano-bio research cross the boundaries between our conventional notions of drugs, devices, and diagnostics. These new materials and devices will initially be judged on their therapeutic merits alone, which are very promising. But when their economic merits are proven, they will bring competition across industry borders, as pharmaceutical companies, device makers, and diagnostics firms seek to own them.
	The Rise Of Nanobiotech And Why The Future Of Technology Is Wet
	Closing Keynote Speaker 2: Mr Tim Harper CEO Cientifica, UK
Technology in the latter half of the 20th century was dominated by solid state physics, the use of hard crystalline materials requiring processing under ultra high vacuum conditions. However the convergence of nano and bio technologies is increasingly shifting technology away from semiconductor style processing to a number of new production technologies looking much more let wet chemistry or biotech. As a result, our understanding of how nature works at the nanoscale is enabling the door to new bionano inspired markets, ranging from semiconductor processing to pharmaceuticals.
Technology Showcase This session highlights some of the exciting nascent technologies and R&D advances that are available within Southeast Asia for potential collaboration and/or investments.

Sponsorship Opportunities

Sponsorship opportunities are available. For more information about sponsoring Technology Commercialization Forum, please contact: